RECRUITING Not applicable ClinicalTrials.gov

Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases

Sponsor: National University of Malaysia • ClinicalTrials.gov ID: NCT07843238

Registry updated: 2026-10-16

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The purpose of this study is to evaluate a newly developed virtual care program for older adults with chronic diseases (hypertension, diabetes and lipid disorders) whether it is feasible and economical to implement in the Malaysian primary healthcare settings. Investigators hypothesize that the use of this virtual care program (TeleCOOP-NCD©) will be more cost-effective (lower total costs per benefits gained) compared to the usual onsite care at the clinic for older adults who have stable chronic diseases. The investigators also hypothesize that there is no significant difference in control of clinical parameters compared to usual care. Researchers will compare the primary outcomes such as patient satisfaction, health-related quality of life, provider cost and patient cost between the intervention and control group. Researchers will also check participant recruitment rate, participant retention rate and clinical parameters (including blood pressure, hemoglobin A1c, fasting blood glucose, fasting serum lipids) as secondary outcomes. Eligible participants will receive either virtual care program (intervention) or usual care (regular in-person visits) at a primary care clinic, called the Klinik Primer of Hospital Canselor Tuanku Muhriz (KP-HCTM), in Bandar Seri Permaisuri, Kuala Lumpur, Malaysia. Researchers will do outcome assessments at baseline, 3 months and 6 months respectively.

Interventions

Teleconsultation care pathway for older adults with NCDs (TeleCOOP-NCD©) (Other)
The intervention is the implementation of a newly designed teleconsultation care pathway for older patients with noncommunicable diseases (TeleCOOP-NCD©) at the primary care clinic of Hospital Canselor Tuanku Muhriz (KP-HCTM). Medical officers and Family Medicine Specialists from the KP-HCTM will provide teleconsultation to participants in the intervention arm, at 3-month and 6-month follow-up visits, according to the TeleCOOP-NCD© care pathway. Each teleconsultation may take around 30 minutes (or more, based on the individual needs of patients). There will be only two times of teleconsultations over the study period of six months for each participant under this arm. The participants can receive the teleconsultation at their homes. The appointments for the two teleconsultations will be scheduled well in advance, and they will be reminded at least one day before the appointment dates respectively.

Eligibility criteria

Inclusion Criteria: * Patients with the age of 60 years and above; * Patients who are literate in either Malay or English language; * Patients who are not frail or mildly frail (with the scores of 0-8 in the Pictorial Fit-Frail Scale assessment); * Patients who are receiving treatment for hypertension, diabetes and/or dyslipidemia (any of the three NCDs); and * Patients who have internet access and know how to operate a smartphone/device or are able to receive assistance for its use from their family members or caregivers. Exclusion Criteria: * Patients who are completely transferred out from the Klinik Primer or Hospital Canselor Tuanku Muhriz (HCTM); * Patients who are newly referred to the clinic and attending their first visit; * Patients who visit the clinic for teaching sessions or non-doctor consultations (allied health, procedures, or prescription refill).

Conditions

Hypertension (HTN) Diabetes Dyslipidaemia

Locations

Klinik Primer - Hospital Canselor Tuanku Muhriz (KP-HCTM) — Kuala Lumpur, Malaysia

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment